课题基金 / 基金详情

Reactivation of Tumor-suppressor MicroRNAs in Cancer Cells by Epigenome Editing

Reactivation of Tumor-suppressor MicroRNAs in Cancer Cells by Epigenome Editing
通过表观基因组编辑重新激活癌细胞中的肿瘤抑制 MicroRNA
批准号:
20K07604
负责人:
Gailhouste Luc
金额:
$2.5万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2020
资助国家:
日本
项目状态:
已结题
起止时间:
2020-04-01 至 2023-03-31

项目摘要

项目成果

Gailhouste Luc的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The objective of this project was to develop a reliable system for targeted demethylation and reactivation of specific cancer-related microRNAs (miRNAs). By adapting the CRISPR-Cas9 system and establishing an innovative editing technology, we have been able to accurately manipulate the epigenome of tumor-suppressor miRNAs for functional analyses and potential therapeutic applications. Thus far, the following aims have been achieved:1. Targeted demethylation of the tumor-suppressor miR-122 using the dCas9-TET1 epigenome editing system2. Identification of miR-122 targets using miRNA epigenome editing3. miR-122 editing negatively impacts hepatic cancer cell growth through SLC2A3 targeting
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
A robust cell culture system for anti-hepatitis B virus drug study via epigenetic reprogramming
通过表观遗传重编程进行抗乙型肝炎病毒药物研究的强大细胞培养系统
DOI: --
发表时间: 2021
期刊:
影响因子: --
作者: [倉橋 祐樹, 嬉野 博志, 蒲池 和晴, 山本 雄大, 渡邉 達郎, 木村 晋也, Luc Gailhouste]
通讯作者: Luc Gailhouste
Epigenome editing technology for the targeted demethylation and reactivation of tumor-suppressor microRNAs
表观基因组编辑技术用于肿瘤抑制 microRNA 的靶向去甲基化和重新激活
DOI: --
发表时间: 2021
期刊:
影响因子: --
作者: [渡邉 達郎, 倉橋 祐樹, 蒲池 和晴, 山本 雄大, 川副 和紀, 嬉野 博志, 末岡 榮三朗, 木村 晋也, Luc Gailhouste]
通讯作者: Luc Gailhouste
Diagnostic and Therapeutic Potential of Circular RNAs in Autism Spectrum Disorder
海外基金